Nordson’s Q3 2026: A High-Backlog Quarter, Higher Revenue Forecast, and the Quiet Power of Margins

Ticker: NDSN | EPS (diluted) 2.73, adjusted EPS 3.25 | Revenue $818 million

Executive snapshot: the quarter, the numbers, and the quiet momentum

The Nordson Corporation delivered its fiscal third quarter results for 2026 with a familiar rhythm: revenue of $818 million, up 10% year over year, underpinned by organic growth of roughly 12% and a backlog that swelled by 35% versus the prior year. On the bottom line, the company reported earnings per diluted share (EPS) of $2.73, a record high for the quarter, while management highlighted an even stronger face value when excluding certain items—adjusted earnings per diluted share came in at $3.25, a 19% year-over-year improvement.

Noticeably, Nordson’s narrative emphasizes momentum rather than drama. The firm cited continued strength in demand, a robust backlog, and a disciplined approach to capital allocation as the levers behind both sales and margin resilience. The press release devotes considerable space to the Ascend Strategy and portfolio diversification as drivers of the quarter’s results, while also noting a constructive free cash flow position that supports balance-sheet strength and capital returns.

From an investor psychology standpoint, the numbers invite the arithmetic of “EPS surprises” in the eye of the market. The report does not present a formal EPS consensus figure in the text, but it does present a narrative of record EPS standings and adjusted metrics. In other words, the earnings surprise angle will be read against consensus and guidance, with the real question being whether the cadence of backlog growth and margin maintenance can sustain into the next chapters of the Ascend Strategy.

Segment spotlight: three engines of the quarter

Industrial Precision Solutions

Sales totaled $367 million, rising 5% year over year. The mix reflects a combination of a 3% organic uplift, a modest 1% currency tailwind, and a 1% contribution from acquisitions. EBITDA was $130 million, equating to 35% of sales, broadly in line with the prior-year third quarter. The margin stability here underscores Nordson’s ability to translate volume into price discipline and operating efficiency even as product cycles and end-market demand evolve.

Medical and Fluid Solutions

At $231 million, this segment posted another all-time quarterly record in sales, up 5% versus the prior year. Excluding the divestiture of a contract manufacturing business, organic growth accelerated to 11%. The EBITDA tally was $88 million, equal to 38% of sales, up 6% year over year, signaling a combination of higher volumes and continued margin discipline in a segment sensitive to mix and cost structure.

Advanced Technology Solutions

Sales reached $220 million, up 28% from the prior year’s third quarter, with organic growth of 31% and a 3% drag from currency. EBITDA within this segment was a record $66 million, or 30% of sales, representing a material margin expansion relative to the year-ago quarter’s $42 million. The growth thread here reflects strength in electronics dispense and test/inspection lines, reinforcing Nordson’s diversified technology portfolio as a hedge against single-market cycles.

Backlog and cash flow: the invisible accelerants

The company notes backlog up 35% versus the prior year, a statistic that translates into visibility for future revenue and a buffer against short-term volatility. The accompanying discussion of free cash flow generation highlights how Nordson funded capital returns while maintaining a solid balance sheet. In an environment where investment and capital discipline matter, the backlog cadence and cash generation matter as much as the quarterly beat, if not more so.

Outlook and guidance: lifting the revenue forecast and earnings trajectory

Nordson reiterated its intent to increase the full-year guidance for both sales and earnings, signaling confidence in the momentum carried into the fourth quarter. The narrative suggests continued strength across segments, supported by backlog and demand-driven demand signals. This framework implies that the revenue forecast for the year remains on an upward trajectory, and the company intends to translate that into further earnings progress, aided by ongoing efficiency initiatives and portfolio strength.

Context and implications: what this portends for Nordson and peers

Nordson’s quarterly results sit at the intersection of durable demand for precision solutions and the company’s own portfolio repositioning under the Ascend Strategy. A 35% backlog lift is more than a number; it’s a signal that customers are investing in manufacturing capabilities and that Nordson’s diversified offerings—industrial, medical, and advanced technologies—are broadly aligned with capex cycles in manufacturing and electronics. The mixed but coherent margin story—flat or expanding across segments despite a high growth rate in Advanced Technology Solutions—suggests that Nordson can sustain profitability even as growth premiums shift between segments.

For peers, the quarter reads like a case study in balance-sheet discipline and portfolio concentration. The lightening-fast growth in Advanced Technology Solutions shows where demand and pricing power can combine when product lines align with secular trends in electronics and test/measurement. The steady performance of Industrial Precision Solutions and the record-setting Medical and Fluid Solutions segment reinforce the value of diversified, asset-light operations with strong service and aftermarket components. Markets will likely watch whether Nordson can maintain this balance as inflation, supply chains, and currency moves continue to press and pull at margins.

Conclusion: a quarter that doesn’t scream “blockbuster” but quietly underpins a durable, diversified growth story

Nordson’s Q3 2026 results illustrate a company that has harnessed its portfolio diversity, backlog momentum, and cash-generative strength to push through what could have been a noisy macro environment. The EPS signal is strong, the adjusted wall of earnings stands taller, and the revenue forecast points higher. In the near term, investors will parse whether the earnings surprise on the top line and the margin-anchoring discipline can translate into sustained annual progress. If the Ascend Strategy is delivering as described, Nordson may not need to shout to be heard—its results might simply keep ticking up in a way that peers will have to chase, quarter after quarter.